Editorial: Inspiring bold ideas and solving big problemsCanadian doctors face big challenges but together we can overcome them Canada's first cannabis-only researcher to explore medicinal potential of 90 unstudied cannabinoidsYang Qu hopes to lead the way in unlocking the full potential of cannabis—both commercially and medicinally—just as he did as one of Canada's foremost anti-cancer drug researchers. Vitals: Biggest influences on the future of family medicine National pharmacare by 2020 would cost $9.7 B in public funding but save more in total costs: analysis A new analysis in CMAJ (Canadian Medical Association Journal) outlines the potential government cost of a national Canadian pharmacare program and sets out approaches to shifting the funding for drugs in Canada to realize billions in savings. Why natural depression therapies are better than pills Antidepressants bring in almost $17 billion a year for the pharmaceutical industry, and yet science shows their benefit to be small Probiotics make no difference to intestinal infections in kids: studies Two studies released by the University of Calgary suggest giving children probiotics to fend off intestinal infections won't make any difference. Shining a spotlight on the opioid crisis New BC-based documentary aims to get the conversation started. Don’t let fear of disciplinary action keep you from expanded scope activities 5 common mental mistakes of the DIY investor Drug spending quickly outpacing spending on doctors and hospitals: CIHI report Drugs for rheumatoid arthritis and Crohn’s disease make up the largest proportion of drug spending in Canada First Previous 305 306 307 308 309 Next Last